PortalPublikationenS1 Guideline: Diagnosis and therapy of vitiligo

S1 Guideline: Diagnosis and therapy of vitiligo

Standard

S1 Guideline: Diagnosis and therapy of vitiligo. / Böhm, Markus; Schunter, Jo Ana; Fritz, Klaus; Salavastru, Carmen; Dargatz, Sonja; Augustin, Matthias; Tanew, Adrian.

in: J DTSCH DERMATOL GES, Jahrgang 20, Nr. 3, 03.2022, S. 365-378.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Böhm, M, Schunter, JA, Fritz, K, Salavastru, C, Dargatz, S, Augustin, M & Tanew, A 2022, 'S1 Guideline: Diagnosis and therapy of vitiligo', J DTSCH DERMATOL GES, Jg. 20, Nr. 3, S. 365-378. https://doi.org/10.1111/ddg.14713

APA

Böhm, M., Schunter, J. A., Fritz, K., Salavastru, C., Dargatz, S., Augustin, M., & Tanew, A. (2022). S1 Guideline: Diagnosis and therapy of vitiligo. J DTSCH DERMATOL GES, 20(3), 365-378. https://doi.org/10.1111/ddg.14713

Vancouver

Böhm M, Schunter JA, Fritz K, Salavastru C, Dargatz S, Augustin M et al. S1 Guideline: Diagnosis and therapy of vitiligo. J DTSCH DERMATOL GES. 2022 Mär;20(3):365-378. https://doi.org/10.1111/ddg.14713

Bibtex

@article{0003797996c54bb09ee9bc47e0c59007,
title = "S1 Guideline: Diagnosis and therapy of vitiligo",
abstract = "Vitiligo is a common skin disorder characterized by immune-mediated destruction of melanocytes. Non-segmental vitiligo, the most common clinical subtype, has usually a chronic course and often results in significant psychosocial consequences for the affected patient. Early recognition, awareness of comorbidity, precise assessment of disease extent and activity, evaluation of impairment of quality of life as well as rapid initiation of treatment based on currently available evidence-based therapies are crucial cornerstones in the management of vitiligo. This S1 guideline helps German dermatologists to better diagnose and treat vitiligo.",
keywords = "Humans, Practice Guidelines as Topic, Vitiligo/diagnosis",
author = "Markus B{\"o}hm and Schunter, {Jo Ana} and Klaus Fritz and Carmen Salavastru and Sonja Dargatz and Matthias Augustin and Adrian Tanew",
note = "{\textcopyright} 2022 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.",
year = "2022",
month = mar,
doi = "10.1111/ddg.14713",
language = "English",
volume = "20",
pages = "365--378",
journal = "J DTSCH DERMATOL GES",
issn = "1610-0379",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - S1 Guideline: Diagnosis and therapy of vitiligo

AU - Böhm, Markus

AU - Schunter, Jo Ana

AU - Fritz, Klaus

AU - Salavastru, Carmen

AU - Dargatz, Sonja

AU - Augustin, Matthias

AU - Tanew, Adrian

N1 - © 2022 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.

PY - 2022/3

Y1 - 2022/3

N2 - Vitiligo is a common skin disorder characterized by immune-mediated destruction of melanocytes. Non-segmental vitiligo, the most common clinical subtype, has usually a chronic course and often results in significant psychosocial consequences for the affected patient. Early recognition, awareness of comorbidity, precise assessment of disease extent and activity, evaluation of impairment of quality of life as well as rapid initiation of treatment based on currently available evidence-based therapies are crucial cornerstones in the management of vitiligo. This S1 guideline helps German dermatologists to better diagnose and treat vitiligo.

AB - Vitiligo is a common skin disorder characterized by immune-mediated destruction of melanocytes. Non-segmental vitiligo, the most common clinical subtype, has usually a chronic course and often results in significant psychosocial consequences for the affected patient. Early recognition, awareness of comorbidity, precise assessment of disease extent and activity, evaluation of impairment of quality of life as well as rapid initiation of treatment based on currently available evidence-based therapies are crucial cornerstones in the management of vitiligo. This S1 guideline helps German dermatologists to better diagnose and treat vitiligo.

KW - Humans

KW - Practice Guidelines as Topic

KW - Vitiligo/diagnosis

U2 - 10.1111/ddg.14713

DO - 10.1111/ddg.14713

M3 - SCORING: Journal article

C2 - 35246935

VL - 20

SP - 365

EP - 378

JO - J DTSCH DERMATOL GES

JF - J DTSCH DERMATOL GES

SN - 1610-0379

IS - 3

ER -